Learn more →
Back to Expert Scholars
AI in Cancer Research / AI+癌症研究Computational Pathology

Andrew H. Beck

M.D., Ph.D.

🏢PathAI🌐USA

CEO and Co-founder

1
Key Papers
2
Key Contributions

👥Biography 个人简介

Andrew Beck is a pathologist-scientist who founded PathAI to develop AI-powered pathology diagnostics. His research at Harvard demonstrated that machine learning could match or exceed pathologist accuracy for certain diagnostic tasks. Beck's company develops AI tools for drug development and clinical diagnostics, partnering with major pharmaceutical companies to accelerate precision medicine.

Andrew Beck是一位病理学家-科学家,创立了PathAI来开发AI驱动的病理诊断。他在哈佛的研究表明,机器学习可以在某些诊断任务上达到或超过病理学家的准确性。Beck的公司开发用于药物开发和临床诊断的AI工具,与主要制药公司合作加速精准医学。

Share:

🧪Research Fields 研究领域

AI PathologyAI病理学
Precision Medicine精准医学
Machine Learning机器学习

🎓Key Contributions 主要贡献

PathAI Platform

Built commercial AI pathology platform used by major pharmaceutical companies.

Clinical Validation

Conducted rigorous clinical validation studies of AI pathology systems.

Representative Works 代表性著作

[1]

Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival

Science Translational Medicine (2011)

Demonstrated prognostic value of computational pathology features.

📄Data Sources 数据来源

Last updated: 2026-03-05 | All information from publicly available academic sources

关注 Andrew H. Beck 的研究动态

Follow Andrew H. Beck's research updates

留下邮箱,当我们发布与 Andrew H. Beck(PathAI)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment